Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts
从患者的角度衡量终身多重发病率:跨队列实施和可视化累积负担方法
基本信息
- 批准号:10590654
- 负责人:
- 金额:$ 66.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-11 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdoptionAdultAdvocacyAffectAgeCaringCatalogsChildChildhoodChildhood Cancer TreatmentChronicClinicalClinical OncologyCohort StudiesComplexConsolidated Framework for Implementation ResearchDataDissemination and ImplementationEnsureEpidemiologic MethodsEpidemiologyEtiologyEventFrequenciesFutureGoalsHealthHealth PersonnelHealth PolicyHealth ServicesHealth system plansHigh PrevalenceIncidenceIndividualInterventionLifeLife Cycle StagesLong Term SurvivorshipMeasuresMethodologyMethodsMorbidity - disease rateOnline SystemsOutcomeOutcomes ResearchOutputPathologyPatient Outcomes AssessmentsPatientsPatternPediatric cohortPersonal SatisfactionPoliciesPolicy MakerPopulationPrevalencePreventionProcessPublishingRecurrenceResearchResearch DesignResearch PersonnelResearch PriorityResourcesRiskRisk FactorsSaint Jude Children&aposs Research HospitalSeveritiesSickle CellSickle Cell AnemiaSocietiesSubgroupTestingTherapeuticTimeVariantVisualVisualizationVisualization softwareVulnerable PopulationsWeightWorkanalytical toolchildhood cancer survivorclinical careclinical decision-makingclinically relevantcohortcomorbiditydesignepidemiology studyhealth related quality of lifeimplementation scienceimprovedindividual patientinnovationinsightinterestmultidisciplinarymultiple chronic conditionsnovelpersonalized predictionspersonalized risk predictionprospectiveresearch studyresponserisk predictionsevere mental illnesssoftware developmenttooltreatment planning
项目摘要
PROJECT SUMMARY/ABSTRACT
Background: Multimorbidity, defined as the co-occurrence of two or more physical or mental chronic illnesses,
is prevalent and rising globally. New measures of multimorbidity that provide unique insights into the spectrum,
pattern and magnitude of multiple co-morbid conditions are needed. Current measures fail to provide adequate
context from which to design, evaluate, and implement multilevel clinically-relevant interventions.
Objective: In response to PAR-20-179, we propose to develop, visualize and apply a modular suite of novel
measures and tools to address the critical limitations currently impacting multimorbidity outcomes research.
Specific Aims: (1) Develop personalized cumulative burden measures, over various stages of the life-course,
based on patient perspectives using condition-weighted burden weights and risk factors; (2) Create a suite of
web-based visualizations for use by any type of cohort; (3) Apply the cumulative burden to an independent
cohort of sickle cell disease patients to test implementation and guide future dissemination to other cohorts.
Study design: Two novel measures, which built on our existing cumulative burden framework, will be
developed using data from the St. Jude Lifetime Cohort (SJLIFE) study, a large clinical cohort of pediatric
cancer survivors. First, we will develop a personalized measure of multimorbidity risk for an individual using a
regression framework of the Poisson process to provide insights into lifelong variations in patterns and
magnitude of multiple chronic conditions and associated key risk factors. Second, we will implement burden
weights, a set of condition-specific weights derived from utility weights (which we will also calculate) using
SJLIFE data in order to incorporate patient perspectives. To use/share the metrics, the Agile approach to
software development will be employed to create dynamic, interactive web-based visualizations. Finally, using
the consolidated framework for implementation research, we will apply the cumulative burden method to study
multimorbidity in a second cohort comprised of adults and children with sickle cell disease in order to advance
national research priorities and study how others may our innovative measures to their cohorts.
Significance: Our cumulative burden measure was created to overcome some of the pressing difficulties with
current multimorbidity measures identified by PAR-20-179. This proposed study seeks to build on our prior
work by incorporating personalized risk prediction and patient-reported outcomes. Additionally, we recognize
that developing new measures and publishing our methods are insufficient to ensure broad use and impact. To
support effective implementation and dissemination, we will create visual tools that help investigators share
cumulative burden results and study the barriers and enablers of their application using an implementation
science approach. We anticipate our work will yield a suite of visualization templates and modular applied
method resources that will enable clinicians, researchers, advocacy groups, and policymakers an opportunity
to shed light on the growing problem of multimorbidity affecting nearly every sub-group of our society.
项目总结/摘要
背景:多发性硬化症,定义为同时发生两种或两种以上的身体或精神慢性疾病,
正在全球范围内流行并不断上升。新的多模态测量方法提供了对频谱的独特见解,
需要多种共病状况的模式和程度。目前的措施未能提供足够的
从设计,评估和实施多层次的临床相关干预措施的背景。
目的:为了响应PAR-20-179,我们建议开发、可视化和应用一套新的模块化套件,
采取措施和工具,以解决目前影响多阶段成果研究的关键限制因素。
具体目标:(1)在生命过程的各个阶段制定个性化的累积负担措施,
基于患者的观点,使用条件加权的负担权重和风险因素;(2)创建一套
基于网络的可视化供任何类型的队列使用;(3)将累积负担应用于独立的
镰状细胞病患者队列,以测试实施情况并指导未来向其他队列的传播。
研究设计:两个新的措施,这是建立在我们现有的累积负担框架,将
使用圣犹达终身队列(SJLIFE)研究的数据开发,这是一项大型儿科临床队列研究,
癌症幸存者首先,我们将开发一个个性化的措施,多发病风险的个人使用
泊松过程的回归框架,以提供对模式终身变化的见解,
多种慢性疾病的严重程度和相关的关键风险因素。二是落实负担
权重,一组特定于条件的权重,来自效用权重(我们也将计算),使用
SJLIFE数据,以纳入患者观点。要使用/共享度量标准,
将利用软件开发来制作动态的、交互式的基于网络的可视化。最后利用
实施研究的综合框架,我们将应用累积负担法进行研究
在第二个由患有镰状细胞病的成年人和儿童组成的队列中进行多项研究,
国家研究优先事项,并研究其他国家如何将我们的创新措施应用于他们的同龄人。
意义:我们的累积负担措施是为了克服一些紧迫的困难,
PAR-20-179确定的当前多项措施。这项拟议的研究旨在建立在我们以前的基础上,
通过结合个性化的风险预测和患者报告的结果来工作。此外,我们认识到,
制定新的措施和公布我们的方法不足以确保广泛使用和影响。到
为了支持有效的实施和传播,我们将创建可视化工具,帮助调查人员共享
累积的负担结果,并研究其应用的障碍和使能因素,
科学方法。我们预计我们的工作将产生一套可视化模板和模块化应用
方法资源,使临床医生,研究人员,倡导团体和政策制定者有机会
揭示日益严重的影响到我们社会几乎每一个亚群体的多重犯罪问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nickhill Hitesh Bhakta其他文献
Nickhill Hitesh Bhakta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nickhill Hitesh Bhakta', 18)}}的其他基金
Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts
从患者的角度衡量终身多重发病率:跨队列实施和可视化累积负担方法
- 批准号:
10421100 - 财政年份:2022
- 资助金额:
$ 66.43万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 66.43万 - 项目类别:
Research Grant